"We are pleased to announce the completion of this important milestone for Stuart Therapeutics and offer our congratulations to our study team. Stuart continues to advance the development of this new ...

The transferrin vectorised therapy is being investigated for use in patients with dry age-related macular degeneration and geographic atrophy PulseSight Therapeutics SAS, a biotechnology firm based in ...

IMPACT Therapeutics (IMPACT), a biopharmaceutical company focusing on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, announced that Senaparib capsules ...

UnitedHealthcare will ease prior authorization requirements for its Medicare Advantage plans, UnitedHealth Group CEO Andrew Witty said Thursday. In his first public remarks since the murder of ...

The procedure is already occurring, Fontana said, with hospitals footing the bill or insurers covering it through the prior authorization process. Fontana said in an interview the analysis ...

Pheno Therapeutics Limited ... announced today it has received clinical trial authorization (CTA) from the UK’s MHRA (Medicines and Healthcare products Regulatory Agency) for its lead candidate ...

January has arrived, and it's brought a whole new batch of quality movies to Prime Video. The streaming service is home to some seriously good entertainment, and this month's no different.

“The CAFC found it plain… that Section 102(e)(1) was simply referencing a specific type of printed publication that becomes prior art as of the date it was filed.” Today, the U.S. Court of ...

The bad news is that the bloom may be coming off the GLP-1 rose, which is presumably the reason why not only Eli Lilly but Novo Nordisk and Viking Therapeutics stock are suffering this morning.

Despite the competitive threat posed by Eli Lilly’s acquisition of Scorpion Therapeutics’ STX-478, which has shown promising efficacy in several cancer types, Relay Therapeutics’ RLY-2608 ...